Table 2.
Characteristic | N | % |
---|---|---|
Sex | ||
Male | 71 | 68% |
Female | 33 | 32% |
Age | ||
<60 | 41 | 40% |
>60 | 63 | 61% |
Ethnicity | ||
Hispanic | 26 | 25% |
Non-Hispanic | 77 | 74% |
Race | ||
White | 65 | 62% |
African-American/Black | 30 | 29% |
Other | 2 | 2% |
Anatomic site | ||
Oral cavity | 31 | 30% |
Oropharynx | 32 | 31% |
Hypopharynx | 9 | 9% |
Larynx | 32 | 31% |
Tumor Stage* | ||
I/II | 24 | 23% |
III/IV | 80 | 77% |
T status | ||
I/II | 46 | 44% |
III/IV | 56 | 54% |
N status | ||
I/II | 40 | 40% |
III/IV | 56 | 54% |
Treatment | ||
Primary chemo/RT | 45 | 43% |
Primary surgery | 33 | 32% |
Surgery -> chemo | 22 | 21% |
Smoking history | ||
Current | 46 | 44% |
Former | 39 | 38% |
Never | 17 | 16% |
Missing | 2 | 2% |
HPV status | ||
HPV16− | 59 | 57% |
HPV16+ | 37 | 36% |
HPV status missing | 8 | 8% |
Total | 104 | 100% |
Some cases pending histological confirmation. Totals may not add up to 104 because of missing data.